Effect of a Health Pathway for People With Persistent Symptoms Covid-19 (SPACO+)
COVID-19
About this trial
This is an interventional supportive care trial for COVID-19 focused on measuring health pathway, quality of life, personalized multifactorial intervention
Eligibility Criteria
Inclusion Criteria Persons who have been infected with Covid-19. Person with persistent clinical signs of Covid-19 for more than 12 weeks, referred by one of the partner structures of the project. The persistent signs of Covid-19 are: fatigue which can be severe, neurological disorders neurological disorders (cognitive, sensory, headaches), cardio-thoracic disorders (pain and chest tightness, tachycardia, dyspnea, cough) and disorders of smell and taste. Pain, digestive disorders and skin disorders are also common. Person who has agreed to participate and has given informed consent to participate in the study Exclusion Criteria: Refused to participate in the study Person under legal protection Person with severe cognitive impairment
Sites / Locations
- Urps Medecins Libéraux Auvergne-Rhône-Alpes
- Chu Saint-Etienne
- Chaire Santé des Aînés
- DAC Loire
Arms of the Study
Arm 1
Arm 2
Other
Experimental
Usual care
Intervention group
usual care and follow-up by a nurse: control group receiving conventional management, i.e. referral to a specialist(s) according to symptoms, as well as nursing follow-up.
usual care and Personalized Multifactorial Intervention: group benefiting from the Personalized Multifactorial Intervention coordinated by a nurse